GeneOne Life Science, Inc. (KRX:011000)
1,191.00
+14.00 (1.19%)
Last updated: May 28, 2026, 2:12 PM KST
GeneOne Life Science Revenue
GeneOne Life Science had revenue of 2.58B KRW in the quarter ending March 31, 2026, a decrease of -69.65%. This brings the company's revenue in the last twelve months to 17.12B, down -53.96% year-over-year. In the year 2025, GeneOne Life Science had annual revenue of 23.04B, down -35.49%.
Revenue (ttm)
17.12B
Revenue Growth
-53.96%
P/S Ratio
6.25
Revenue / Employee
417.61M
Employees
41
Market Cap
106.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.04B | -12.68B | -35.49% |
| Dec 31, 2024 | 35.72B | -4.48B | -11.15% |
| Dec 31, 2023 | 40.20B | -8.52B | -17.48% |
| Dec 31, 2022 | 48.72B | 10.02B | 25.89% |
| Dec 31, 2021 | 38.70B | -2.80B | -6.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Macrogen | 199.60B |
| Amicogen | 43.44B |
| CG Invites | 29.22B |
| Prestige BioPharma | 19.02B |
| Genexine | 5.81B |
| iNtRON Biotechnology | 5.74B |
| IMB Dx | 5.33B |
| ENCell | 5.26B |